PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)

Clinical trial NCT03671967 · RECRUITING

Trial details

NCT number: NCT03671967
Sponsor: Rambam Health Care Campus
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Beta Lactam Resistant Bacterial Infection Enterobacteriaceae Infections Bacteremia

Start date: 2019-05-01
Primary completion: 2027-01-01
Enrollment: 1084

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.